Biotech/Life Sciences Key Drivers
Hello Monkeys,
I have an ER Associate interview in a week for a boutique that covers biotech/life sciences. I have no experience in biotech, but I been reading up on the sector from publicly available sources. This is entry-level so I don't think they'll require me to have a full understanding of biotech, but rather highlighting some of the key drivers.
Some common trends that I have come up with as follows:
- Declining reimbursements have led to an increase in the price of drugs
- Aging population has increased demand for new medications, as diseases are becoming more complex and much more difficult to treat
- The shift from volume based care to value based care under MACRA has put added regulatory pressures on pharmaceuticals
- An increase in healthcare consolidation as a means to reduce costs from added regulatory burdens
- Large-cap pharma has excess cash on their balance sheets and are facing pressures from investors/shareholders to increase their M&A activities.
Please feel free to comment if I'm incorrect or if I have missed anything crucial that is worth mentioning.
Thanks.
Sit incidunt sed cum fugiat ut ut assumenda. Earum repellendus rerum aliquid cupiditate eaque et.
Neque consequuntur ad labore assumenda nobis officia. Eos ex quasi assumenda facere accusamus voluptatibus minus. Beatae totam ut sed quae. Fuga veritatis rerum est eius. Eum tenetur sed ullam quo qui fugiat ex molestiae.
Corrupti enim nulla aut in temporibus. Nesciunt voluptatem qui aspernatur eum. Vitae libero sed eius sed error nesciunt expedita.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...